Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1/2 1

Status

Unknown 5

Sponsor Class

OTHER 5

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

CNS 5

Conditions

Stomach Neoplasms 57Carcinoma, Hepatocellular 44Carcinoma, Non-Small-Cell Lung 23Small Cell Lung Carcinoma 19Ovarian Neoplasms 18Colorectal Neoplasms 18Breast Neoplasms 17Sarcoma 14Neoplasms 14Triple Negative Breast Neoplasms 13Nasopharyngeal Carcinoma 11Lung Neoplasms 10Esophageal Squamous Cell Carcinoma 10Cholangiocarcinoma 10Osteosarcoma 9Esophageal Neoplasms 9Advanced Gastric Cancer 9Neoplasm Metastasis 8Biliary Tract Neoplasms 8Uterine Cervical Neoplasms 6Squamous Cell Carcinoma of Head and Neck 6Recurrence 6Pancreatic Neoplasms 6Head and Neck Neoplasms 6Liver Neoplasms 5Glioma 5Thyroid Neoplasms 4Solid Tumor 4Melanoma 4Drug-Related Side Effects and Adverse Reactions 4

Interventions

Temozolomide 159Bevacizumab 69Radiotherapy 68Magnetic Resonance Spectroscopy 68Irinotecan 31Surgical Procedures, Operative 27Radiation 24Carboplatin 23Specimen Handling 20Carmustine 20Blood Specimen Collection 20Nivolumab 19Aminolevulinic Acid 18Biopsy 17Lomustine 15pembrolizumab 13Radiotherapy, Intensity-Modulated 13Cyclophosphamide 13trametinib 12fluorodopa F 18 12X-Rays 12Radiosurgery 12Erlotinib Hydrochloride 12Topotecan 11Everolimus 11Magnetic Resonance Imaging 10IL13-PE38 10dabrafenib 9Etoposide 9Drug Therapy 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Glioma × apatinib × Clear all
NCT04216550 2021-02-08

Prediction of Therapeutic Response of Apatinib in Recurrent Gliomas

The First Affiliated Hospital of Zhengzhou University

Unknown
600 enrolled
CNS

Glioma

NCT04588987 2020-10-19

Neoadjuvant Carilizumab and Apatinib for Recurrent High-Grade Glioma

Sun Yat-sen University

Phase 2 Unknown
60 enrolled
CNS

Glioma

NCT03741244 2019-07-23

TMZ Plus Apatinib in Newly Diagnosed High-grade Glioma:RCT

The Second Hospital of Hebei Medical University

Phase 2 Unknown
211 enrolled
CNS

Glioma

NCT03390062 2018-01-04

A Study of Apatinib in Recurrent or Recurrent High-grade Glioma

West China Hospital

Phase 2 Unknown
30 enrolled
CNS

Glioma

NCT02848794 2017-06-16

Apatinib and Irinotecan in Treating Patients With Recurrent High-grade Glioma

The First People's Hospital of Lianyungang

Phase 1/2 Unknown
40 enrolled
CNS

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡